May 27, 2020

Utah Researcher Awarded Prestigious Grant to Study New Ways to Detect Brain Tumors

Hunter Underhill, MD, PhD, a Huntsman Cancer Institute brain cancer researcher and assistant professor of pediatrics at the University of Utah, was awarded a special National Cancer Institute grant to advance his research in brain tumor detection. Underhill will pursue new ways to detect glioblastoma, a type of aggressive and deadly brain tumor.

May 08, 2020

2020 State of Huntsman Cancer Institute Address

On May 6, 2020, Huntsman Cancer Institute (HCI) CEO Mary Beckerle, PhD, gave her State of HCI address. This event is an annual tradition at HCI, where the CEO reports on progress of the past year and plans for the future. Less ordinary during this global coronavirus pandemic, however, was the format. Dr. Beckerle spoke to faculty and staff safely via live video stream.

Apr 29, 2020

Researchers Find New Insights Linking Cell Division to Cancer

Scientists at Huntsman Cancer Institute at the University of Utah and collaborators at the University of California, San Francisco published research in the journal Nature extending our understanding of the process of cell division. They discovered the protein LEM2 has two important functions during cell division.

Apr 24, 2020

Research Advancing Individualized Treatment for Metastatic Prostate Cancers

Prostate cancer is the second most common cancer for men in the United States. About one man in nine will be diagnosed with the disease at some point in his life. A study recently published in The Lancet’s EBioMedicine Journal describes new insights into how unique genetic traits of metastatic prostate tumors that are shed into the blood of cancer patients can be used for applying to the care of and potential molecularly targeted treatments in individual patients.

Apr 23, 2020

Working to Reduce Cancer Health Disparities in the Mountain West

Huntsman Cancer Institute’s Geographic Management of Cancer Health Disparities program (GMaP) is an initiative of HCI’s Office of Diversity and Inclusion and is part of a nationwide program by the National Cancer Institute. Organizations from seven hubs across the country work to reduce cancer health disparities and support career development for researchers and trainees who work on cancer health disparities.

Mar 09, 2020

HCI Post-Doctoral Fellow Receives Award from the National Cancer Institute

Aria Vaishnavi, PhD, a post-doctoral fellow at Huntsman Cancer Institute at the University of Utah has received the first annual National Cancer Institute Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers. The “Early K99” grant supports researchers who need only a short period of training and mentorship after their doctoral degrees and before they’re hired into a faculty position.

Mar 04, 2020

Paving the Way for Indigenous Scholars

The PathMaker Program definitely had a significant impact on my career path. It was what opened the door to the research world and provided me with the support I needed even after completing the program. I learned that even though my internship ended, the relationships and contacts I gained in the program did not. PathMaker has helped me in every step of my career, and I will be forever grateful.

Mar 03, 2020

HCI Researcher Finds Possible Reason for Lung Cancer Driver

About one-third of lung cancer patients who have never smoked have a small portion of DNA missing in the gene called EGFR. This missing portion is a mutation that drives cancer and causes tumors. In a recent study, Lyska Emerson, MD, looked at the patterns of four non-mutated EGFR genes. She was in search of a “destabilizing DNA sequence.” This sequence could explain why that portion of the DNA—called the exon 19 deletion—goes missing in some people.